author-photo

Weijun Fu

157

Papers

1830

Citations

Citation Trend

Filter By

Papers (118) Sort By

Journal Conference Others

MP10-03 SUPER TRANSURETHRAL BLADDER TUMOR RESECTION

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Application of Polymer Clip to Ligate the Distal Ureter in Retroperitoneal Laparoscopic Radical Nephroureterectomy

2021
Show All
- Source
- Cite
- Save
Citations (0)
Long-term follow-up results of a multicenter first-in-human study of the dual BCMA/CD19 Targeted FasT CAR-T GC012F for patients with relapsed/refractory multiple myeloma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Results of the phase 2 MARCH Study: Oral ATG-010 (Selinexor) plus low dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma (RRMM) previously treated with an immunomodulatory agent (IMiD) and a proteasome inhibitor (PI).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P-211: Phase 2 MARCH study: ATG-010 plus Dexamethasone in Chinese relapsed/refractory Multiple Myeloma (RRMM) patients previously treated with an immunomodulatory agent (IMiD) and a proteasome inhibitor (PI)

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
A 10-Year Monitoring of Soil Properties Dynamics and Soil Fertility Evaluation in Chinese Hickory Plantation Regions of Southeastern China

2021
Show All
- Source
- Cite
- Save
Citations (0)
Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab, bortezomib, and dexamethasone versus bortezomib and dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: phase 3 LEPUS (MMY3009) study

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)